Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06189703

tRNS Treatment for ADHD Symptoms

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
146 (estimated)
Sponsor
Innosphere · Industry
Sex
All
Age
7 Years – 12 Years
Healthy volunteers
Not accepted

Summary

A randomized, sham-controlled, double-blind clinical trial to examine the safety and effectiveness of tRNS on unmedicated pediatric patients (7-12 years) with ADHD. Subjects will undergo either tRNS or sham treatment for 10 days during a two-week period in a home-simulated environment. Each treatment session is 20 minutes, during which their attention will be maintained using a software game.

Conditions

Interventions

TypeNameDescription
DEVICEtRNStranscranial random noise stimulation applied to the right IFG and the left DLPFC

Timeline

Start date
2024-07-15
Primary completion
2026-05-30
Completion
2026-05-30
First posted
2024-01-03
Last updated
2026-02-17

Locations

5 sites across 2 countries: United States, Israel

Regulatory

Source: ClinicalTrials.gov record NCT06189703. Inclusion in this directory is not an endorsement.

tRNS Treatment for ADHD Symptoms (NCT06189703) · Clinical Trials Directory